CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
Karol Szlachta(St. Jude Children's Research Hospital), Mazhar Adli(University of Virginia)
Cited by 78
Related Papers
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
|PLoS Genetics|2008|1k
IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical Pathway
|PLoS ONE|2010|116
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
|Proceedings of the National Academy of Sciences|2020|113